What is Doctor's Data?
Doctor's Data, Inc. (DDI) operates as a premier clinical laboratory specializing in the analysis of essential and toxic elements across various human tissues. The company provides a comprehensive suite of functional testing designed to assist medical professionals in the detection, prevention, and management of heavy metal toxicity, nutritional deficiencies, and gastrointestinal dysfunction. With a focus on hepatic detoxification and metabolic health, DDI serves as a vital partner for clinicians addressing diseases of environmental origin. Their laboratory infrastructure is engineered to support high-precision diagnostics, ensuring that practitioners receive actionable data to optimize patient outcomes in an increasingly complex healthcare landscape.
How much funding has Doctor's Data raised?
Doctor's Data has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Doctor's Data
PPP
Public-Private Partnership
What's next for Doctor's Data?
With the recent infusion of capital, Doctor's Data is well-positioned to scale its diagnostic capabilities and expand its reach within the global functional medicine market. The strategic allocation of these funds will likely prioritize the enhancement of laboratory automation and the integration of advanced analytical technologies to meet the rising demand for personalized health assessments. As the company navigates its current lifecycle stage, the focus remains on maintaining its reputation for scientific rigor while scaling operations to support a broader network of international healthcare providers. Future growth initiatives will likely center on diversifying their testing portfolio to address emerging environmental health challenges and strengthening their digital infrastructure for seamless practitioner integration.
See full Doctor's Data company page
